San Antonio College Library

Argues that the pharmaceutical industry has shifted its focus from research and development to marketing, contending that a small number of corporations are having a disproportionate influence on the global health-care agenda.

"During the last thirty years we have witnessed sweeping changes in health care worldwide, including new and expensive biomedical technologies, an increasingly powerful and influential pharmaceutical industry, steadily increasing health care costs in industrialised nations, and new threats to medical professionalism. The essays collected in this book concern costs and profits in relation to just health care, the often controversial practices of pharmaceutical...

In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical...

"While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public...

"Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers,...

Public perceptions of mental health issues have changed dramatically over the last fifteen years, and nowhere more than in the rampant overmedication of ordinary Americans. In 2006, 227 million antidepressant prescriptions were dispensed in the United States, more than any other class of medication; that year, the United States accounted for 66% of the global market. Here, psychiatrist Barber provides a context for this disturbing phenomenon. He explores...

Reveals how womens' sexual difficulties are being repackaged as symptoms of a new disorder and investigates the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it.

"The Pharmaceutical Industry: Is Pharmaceutical Research Safe and Unbiased?; Are Prescription Drugs Appropriately Regulated?; Are Pharmaceutical Marketing Practices Ethical?; Is the Cost of Prescription Drugs in America Appropriate?"--Provided by publisher. Presents essays with opposing viewpoints on problems of drug testing, safety, regulation, and cost.